|
LDHB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.69699818034042E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2435996676885E-10 |
| Normal-vs-Stage2 |
7.413100E-04 |
| Normal-vs-Stage3 |
3.922600E-03 |
| Normal-vs-Stage4 |
8.205400E-01 |
| Stage1-vs-Stage2 |
9.531400E-01 |
| Stage1-vs-Stage3 |
2.865600E-01 |
| Stage1-vs-Stage4 |
1.531430E-01 |
| Stage2-vs-Stage3 |
4.283000E-01 |
| Stage2-vs-Stage4 |
1.005170E-01 |
| Stage3-vs-Stage4 |
2.180000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.53059803614997E-11 |
| Normal-vs-AfricanAmerican |
1.589500E-04 |
| Normal-vs-Asian |
1.603160E-01 |
| Caucasian-vs-AfricanAmerican |
3.057200E-01 |
| Caucasian-vs-Asian |
8.228000E-01 |
| AfricanAmerican-vs-Asian |
8.742600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.51083656275387E-12 |
| Normal-vs-Female |
1.84670000002995E-06 |
| Male-vs-Female |
1.915230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.41540000000185E-05 |
| Normal-vs-Extreme_Weight |
2.80959999710007E-09 |
| Normal-vs-Obese |
4.87080000000084E-06 |
| Normal-vs-Extreme_Obese |
1.60663999999588E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.258200E-01 |
| Normal_Weight-vs-Obese |
8.045200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.115800E-01 |
| Extreme_Weight-vs-Obese |
4.567200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.241800E-01 |
| Obese-vs-Extreme_Obese |
5.619000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.619700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.56410037436217E-10 |
| Normal-vs-Age(61-80Yrs) |
2.50790055389416E-10 |
| Normal-vs-Age(81-100Yrs) |
1.180010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.531600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.877400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.366800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.940800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.353200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.474600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.73694392202606E-12 |
| Normal-VS-Type2 PRCC |
1.095600E-02 |
| Normal-VS-KIRP CIMP |
1.68479999951288E-08 |
| Normal-VS-Unclassified PRCC |
1.602800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.036260E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.662200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.666640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.042700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.992400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.133600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.51939999973416E-08 |
| Normal-vs-N1 |
2.086200E-01 |
| Normal-vs-N2 |
1.700250E-02 |
| N0-vs-N1 |
1.354980E-01 |
| N0-vs-N2 |
6.172600E-01 |
| N1-vs-N2 |
7.162400E-01 |
|
|
